Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03467919 · ClinicalTrials.gov registry record · Phase 3

The Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis

A Phase 3 study, sponsored by Stanford University.

Completed
Registry status
Phase 3
Development phase
40
Enrollment target

NCT03467919: Completed Phase 3 study, sponsored by Stanford University.

NCT03467919 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 40 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03467919, a Phase 3 study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 3
Development phase
40 participants
Enrollment target

Study Summary

This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.

Primary Outcome

Patient reported outcome measure that reports a normalized score (100 indicating no symptoms and 0 indicating extreme symptoms).

Interventions

  • BIOLOGICAL Micro Fragmented Adipose Tissue
  • BIOLOGICAL Corticosteroid injection

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-04-01
Est. Completion 2024-10-29
Phase Phase 3
Stanford University

1,744 total trials

What the finished NCT03467919 record still lists

NCT03467919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Micro Fragmented Adipose Tissue is the first listed.

NCT03467919 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03467919 about?

NCT03467919 is a clinical study titled "The Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis". This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.

What is the current status of trial NCT03467919?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2018-04-01. Estimated completion is 2024-10-29.

What interventions are being tested in trial NCT03467919?

The interventions under investigation include: Micro Fragmented Adipose Tissue (BIOLOGICAL), Corticosteroid injection (BIOLOGICAL).

Who is sponsoring clinical trial NCT03467919?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03467919's enrollment target sits among peer trials

40 1878th of 2000 higher than 103 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03467919, the US trial registry maintained by the National Library of Medicine. NCT03467919 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.